Natera, Inc. (NTRA)

↓ Download CSV

CIK 0001604821 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Natera, Inc. reported revenue of $2.31B, up 35.9% from the prior year. The company ran a net loss, with a net margin of -9.0%. It held $2.40B in total assets against $685.93M in total liabilities.

Key ratios (FY2025)

-13.4%
Operating margin
-9.0%
Net margin
-12.2%
Return on equity
+35.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$2.31B$1.70B$1.08B$820.22M$625.49M$391.00M$302.33M$257.65M$209.62M$212.51M
Cost of Revenue$158.08M$135.51M$134.49M
Operating Income-$309.91M-$222.29M-$446.25M-$541.04M-$468.17M-$216.28M-$116.29M-$114.63M-$135.34M-$101.05M
Net Income-$208.16M-$190.43M-$434.80M-$547.80M-$471.72M-$229.74M-$124.83M-$128.15M-$137.63M-$100.33M
EPS (Diluted)$-1.52$-1.53$-3.78$-5.57$-5.21$-2.84$-1.79$-2.22$-2.59$-1.95
Total Assets$2.40B$1.66B$1.44B$1.39B$1.24B$932.15M$582.66M$268.17M$214.61M$210.68M
Total Liabilities$685.93M$465.31M$676.37M$688.73M$583.18M$445.92M$303.94M$236.01M$189.20M$104.20M
Shareholders' Equity$1.71B$1.20B$765.33M$705.74M$653.30M$486.24M$278.71M$32.16M$25.42M$143.58M
Cash & Equivalents$466.00M$84.39M$48.67M$61.93M$46.41M$12.62M$15.26M
Operating Cash Flow$215.30M$135.66M-$246.96M-$431.50M-$335.24M-$182.51M-$63.44M-$70.58M-$97.83M-$74.05M
Capital Expenditures$106.19M$66.42M$39.20M$47.70M$41.03M$19.60M$4.97M$3.88M$9.87M$23.14M
Shares Outstanding139.69M132.65M119.58M111.25M95.14M86.22M78.00M62.08M54.04M52.66M